| Landscape and selection of vaccine epitopes in SARS-CoV-2 CC Smith, KS Olsen, KM Gentry, M Sambade, W Beck, J Garness, ... Genome medicine 13 (1), 101, 2021 | 42 | 2021 |
| LENS: landscape of effective neoantigens software SP Vensko, K Olsen, D Bortone, CC Smith, S Chai, W Beckabir, M Fini, ... Bioinformatics 39 (6), btad322, 2023 | 9 | 2023 |
| A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or disease VK Baxter, EJ Anderson, SA Taft-Benz, K Olsen, M Sambade, KM Gentry, ... bioRxiv, 2022.02. 22.481499, 2022 | 1 | 2022 |
| ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity model JS Lee, D Karthikeyan, M Fini, BG Vincent, A Rubinsteyn Briefings in Bioinformatics 25 (1), bbad495, 2024 | | 2024 |
| 848 Predictions of endogenous neoantigens from varied genomic sources in a syngeneic murine cancer model W Beckabir, M Fini, S Vensko, J Alley, M Sambade, A Truong, M Zhou, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| SARS-CoV-2 peptide vaccine elicits T-cell responses in mice but does not protect against infection or disease (preprint) VK Baxter, EJ Anderson, SA Taft-Benz, KS Olsen, M Sambade, WA Beck, ... | | 2022 |
| 478 Translation of a therapeutic neoantigen vaccine workflow to SARS-CoV-2 vaccine development C Smith, S Entwistle, C Willis, S Vensko, W Beck, J Garness, M Sambade, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| SARS-CoV-2 peptide vaccine elicits T-cell responses in mice but does not protect against infection or VK Baxter, EJ Anderson, SA Taft-Benz, K Olsen, M Sambade, KM Gentry, ... | | |
